The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.

FDA vaccine oversight is shifting, with increased scrutiny and mixed messaging sparking concerns among health experts.

There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...

Novo Nordisk has hired multiple lobbying firms to persuade lawmakers to take a harder line on companies producing versions of ...

Attorney General Pam Bondi traveled to a Drug Enforcement Administration lab to meet with chemists who are tasked with ...

The head of the Food and Drug Administration has repeatedly claimed in recent interviews that no scientists have been laid ...

The testing of Grade A dairy products like pasteurized and raw milk, cheese, and yogurt are currently being paused by the FDA ...

This is the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...

Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the ...

After staff and funding cuts across the HHS, the FDA has suspended its quality control program for testing dairy products.

They cited concerns about a possible link between consumption of the dyes and health conditions like ADHD, obesity and ...

The new FDA chief reiterated his commitment to speeding up drug approval processes and run the agency by “gold standard ...